modafinil norge - An Overview
No distinct dose adjustment recommended when tofacitinib coadministered with powerful CYP2C19 inhibitors; lessen tofacitinib dose if coadministered with each moderate CYP3A4 and potent CYP2C19 inhibitors .Hepatic impairment: In clients with severe hepatic impairment, modafinil dose needs to be lessened by one-half of the standard dosage indicated